Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

Everest Medicines Signs MOU with CR Pharma to Form mRNA Company

publication date: Apr 8, 2022

Shanghai Everest Medicines signed a memorandum of understanding with China Resources Pharmaceutical Group to form a partnered mRNA company. In September 2021, Everest announced a $500 million deal with Providence Pharma, a Canadian mRNA company, to develop Providence’s mRNA products in China including a clinical stage mRNA COVID-19 vaccine. The new mRNA partnership with CR Pharma will be built on Everest’s Providence-based portfolio, which includes several COVID vaccines and mRNA oncology candidates. Everest, which will be the controlling shareholder of the mRNA Co., did not disclose financial details. More details....

Stock Symbols: (HK 1952) (HK: 3320)

Share this with colleagues:  


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital